In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...